InRecovery

4 statements across 1 episodes · 1 bullish · 1 bearish · 2 people on the record · first statement Mar 3, 2025 by Charles Hudson · said 11 times in 1 episodes since 2025 · across every show →

Mentions by year

brought up most by David Sarabia (10), Josh Muccio (1)

tap a year for its mentions
00811512025episodesmentions
0112025episodes it came up in
007.50.51512025episodesmentions per episode
2025 11 mentions in 1 episode

every mention, scene by scene, with the transcript →

Everything said about InRecovery, oldest first

Mar 3, 2025 bearish
Disclosure
Hudson passes on InRecovery over unproven clinic sales economics
“So for now, with where the business is, it isn't quite right for me, and I'd pass, but I would be happy to revisit the conversation and”
Charles Hudson Mar 3, 2025 ▶ 14:50 #37 Can Tech Solve America’s Drug Crisis?
Mar 3, 2025 neutral
Assertion Not checkable as stated
Sarabia spent 15 days undercover in rehab for product research
“So I was there 15 days.”
David Sarabia Mar 3, 2025 ▶ 19:56 #37 Can Tech Solve America’s Drug Crisis?
Mar 3, 2025
Disclosure
InRecovery is running its first pilot with 200 patients in LA
“We're in pilot right now, so we have our first pilot where they're using it with a population of 200 people in LA.”
David Sarabia Mar 3, 2025 ▶ 3:25 #37 Can Tech Solve America’s Drug Crisis?
Mar 3, 2025 bullish
Disclosure
Sarabia: InRecovery has raised nearly $500k and targets $1.5M seed round
“So I've managed to raise almost that amount. We have so many VCs that are so interested in us right now that I think that we're gonna end up just securing a seed round, a proper seed round of 1.5.”
David Sarabia Mar 3, 2025 ▶ 25:18 #37 Can Tech Solve America’s Drug Crisis?
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 100 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.